Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in FATE — Fate Therapeutics Inc

CIK 1603466 STAMFORD, CT
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,194,015
+$1,142,273 QoQ
Shares Held
442,228
+925.6% QoQ
Ownership
0.369%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 156 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. FATE ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in FATE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,194,015 442,228
2026-03-31 $51,742 43,119
2025-12-31 $1,497,426 1,527,986
2024-03-31 $11,628,762 1,584,300
2023-12-31 $13,049,469 3,489,163
2023-09-30 $155,610 73,401
2023-06-30 $48,247 10,136
2020-09-30 $6,058,013 151,564
2020-06-30 $11,213,743 326,836